FDA 483 - Pure Source LLC - October 21, 2025

The provided document content for analysis was entirely empty, containing only page markers such as 'Page 1 of 8' without any actual text from an FDA 483 report. As a result, it was impossible to extract any specific details regarding a company name, inspection dates, main violations or issues identified, the applicable regulatory framework, or any required corrective actions. Without the substantive information typically present in an FDA 483 document, a comprehensive summary detailing findings from an inspection cannot be generated. The absence of content prevents any meaningful analysis or synthesis of information that would normally outline significant objectionable conditions observed by the FDA.